My Locations
Siteman Cancer Center at Barnes-Jewish West County Hospital
Siteman Cancer Center at Memorial Hospital Shiloh
Expertise & Training
Ron Bose, MD, PhD
3 minsWashington University medical oncologist Ron Bose, MD, PhD, discusses what breast cancer patients can expect from their extended care team at Siteman Cancer Center. Learn more about Dr. Bose: https://siteman.wustl.edu/doctor/bose-ron/
Learn more about the Siteman Approach to Breast Cancer: https://siteman.wustl.edu/treatment/cancer-types/breast-cancer/our-approach/
Learn more about all breast cancer treatment options at Siteman Cancer Center: https://siteman.wustl.edu/treatment/cancer-types/breast-cancer/treatments/
Hear from Siteman patients who discuss their journey with breast cancer diagnosis, treatment and recovery: https://siteman.wustl.edu/treatment/cancer-types/breast-cancer/patient-stories/
Clinical Expertise
Breast Cancer
Primary Academic Title
Associate Professor of Medicine, Division of Oncology, WashU Medicine
Board Certification
- 2002: American Board of Internal Medicine, Internal Medicine
- 2004: American Board of Internal Medicine, Medical Oncology
Training
- 1999 - 2002: Intern and Resident, Internal Medicine, WashU Medicine, St. Louis, MO
- 2002 - 2007: Fellow, Medical Oncology, Johns Hopkins University, Baltimore, MD
Education
- 1998: PhD, Pharmacology and Biochemistry, Cornell University, New York, NY
- 1999: MD, Cornell University, New York, NY
Research & Selected Publications
Research Interest
HER2-positive breast cancer is a subtype of breast cancer where the HER2/neu tyrosine kinase drives the proliferation of cancer cells by activating a biochemical signaling pathway. We study this pathway using the techniques of proteomics and mass spectometry, coupled with traditional biochemistry and cell biology approaches.
Research Publications